<p>Numbers are mean (SD) or n (%).</p>a<p>The Wilcoxon rank-sum test was used to compare baseline characteristics between those treated early versus those treated during chronic infection.</p>b<p>Two individuals identified as Male-to-Female transgender.</p><p>Baseline characteristics of the subjects.</p
<p>Data are expressed as mean (SD) or percent of patients. UACR, urinary albumin-creatinine ratio; G...
<p>The parameters were described as the mean ± SD at baseline in each group.</p><p>Baseline characte...
<p>a With Bonferroni correction.</p><p>Baseline characteristics of patients categorized according to...
<p>*Wilcoxon Signed-Rank Tests between the two groups ‚No ESRD‘ and ‚ESRD‘ revealed significant diff...
<p>* p <0.001 between men and women</p><p>Baseline characteristics of study participants.</p
<p>M, male; F, female.</p><p>Baseline characteristics of the enrolled patients.</p
<p>Demographic characteristics of study participants, comparing transgender women and cisgender men....
<p>Baseline characteristics stratified by gender of the patients enrolled in the IDI Research Cohort...
<p>The continuous variables are expressed as mean ± SD and the categorical variables as frequency (%...
<p>Values are Mean +/- SD, <i>P</i>1 is the probability for the comparison between females and males...
<p>Baseline characteristics of T1D patients (N = 109) segregated for females and males.</p
<p>Comparison of Characteristics of Participants at Baseline and Years 1 and 2 by Sex (n = 80).</p
<p>Data are expressed as mean (SD) except for gender, which is expressed as number (%).</p><p>*The a...
<p>*Fisher's exact test</p><p>**Wilcoxon Rank Sum test</p><p>Baseline characteristics at inclusion a...
<p>Data are shown as mean ± SD (95% confidence intervals) or n (%).</p><p>Baseline characteristics o...
<p>Data are expressed as mean (SD) or percent of patients. UACR, urinary albumin-creatinine ratio; G...
<p>The parameters were described as the mean ± SD at baseline in each group.</p><p>Baseline characte...
<p>a With Bonferroni correction.</p><p>Baseline characteristics of patients categorized according to...
<p>*Wilcoxon Signed-Rank Tests between the two groups ‚No ESRD‘ and ‚ESRD‘ revealed significant diff...
<p>* p <0.001 between men and women</p><p>Baseline characteristics of study participants.</p
<p>M, male; F, female.</p><p>Baseline characteristics of the enrolled patients.</p
<p>Demographic characteristics of study participants, comparing transgender women and cisgender men....
<p>Baseline characteristics stratified by gender of the patients enrolled in the IDI Research Cohort...
<p>The continuous variables are expressed as mean ± SD and the categorical variables as frequency (%...
<p>Values are Mean +/- SD, <i>P</i>1 is the probability for the comparison between females and males...
<p>Baseline characteristics of T1D patients (N = 109) segregated for females and males.</p
<p>Comparison of Characteristics of Participants at Baseline and Years 1 and 2 by Sex (n = 80).</p
<p>Data are expressed as mean (SD) except for gender, which is expressed as number (%).</p><p>*The a...
<p>*Fisher's exact test</p><p>**Wilcoxon Rank Sum test</p><p>Baseline characteristics at inclusion a...
<p>Data are shown as mean ± SD (95% confidence intervals) or n (%).</p><p>Baseline characteristics o...
<p>Data are expressed as mean (SD) or percent of patients. UACR, urinary albumin-creatinine ratio; G...
<p>The parameters were described as the mean ± SD at baseline in each group.</p><p>Baseline characte...
<p>a With Bonferroni correction.</p><p>Baseline characteristics of patients categorized according to...